Marginal dietary zinc deficiency in vivo induces vascular smoothmuscle cell apoptosis in large arteries

Cardiovascular Research

Volumn 99, Issue 3, 2013, Pages 525-534

  Allen Redpath, Keith ^a   Ou, Ou ^b   Beattie, John H ^b   Kwun, In Sook ^c   Feldmann, Jorg ^a   Nixon, Graeme F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c Andong National University   (South Korea)

Author keywords

Apoptosis; Artery; Vascular smooth muscle cell; Zinc deficiency

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BCL 2; ZINC; BAD PROTEIN, RAT; CALCINEURIN; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CAROTID ARTERY; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MARGINAL DIETARY ZINC DEFICIENCY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE CELL; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ANIMAL; ARTERY; BLOOD; CAROTID ARTERY DISEASE; DISEASE MODEL; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; CAROTID ARTERY DISEASES; DEFICIENCY;

APOPTOSIS; ARTERY; VASCULAR SMOOTH MUSCLE CELL; ZINC DEFICIENCY;

ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CALCINEURIN; CALCIUM; CAROTID ARTERY DISEASES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MAP KINASE SIGNALING SYSTEM; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PHOSPHORYLATION; RATS; ZINC;

EID: 84881291815     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt114     Document Type: Article

References (32)

1. Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr 2009;28:257-265.
2. Hambidge KM, Miller LV, Westcott JE, Sheng X, Krebs NF. Zinc bioavailability and homeostasis. Am J Clin Nutr 2010;91:1478S-1483S.
3. ChasapisCT, LoutsidouAC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol 2012;86:521-534.
4. Wong CP, Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Mol Nutr Food Res 2012;56:77-87.
5. Kim J, Paik HY, Joung H, Woodhouse LR, Li S, King JC. Effect of dietary phytate on zinc homeostasis in young and elderly Korean women. J Am Coll Nutr 2007;26:1-9.
6. Vasto S, Mocchegiani E, Malavolta M, Cuppari I, Listi F, NuzzoDet al. Zinc and inflammatory/ immune response in aging. Ann N Y Acad Sci 2007;1100:111-122.
7. Beattie JH, Kwun IS. Is zinc deficiency a risk factor for atherosclerosis. Brit J Nutr 2004;91: 177-181.
8. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998;17:564-570.
9. GiannoglouGD, Konstantinou DM, Kovatsi L, Chatzizisis YS, Mikhailidis DP. Association of reduced zinc status with angiographically severe coronary atherosclerosis: a pilot study. Angiology 2010;61:449-455.
10. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW et al. Zinc decreases Creactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 2010;91: 1634-1641.
11. Beattie JH, Gordon M-J, Duthie SJ, McNeil CJ, HorganGW, Nixon GF et al. Sub-optimal dietary zinc intake promotes vascular inflammation and atherogenesis in a mouse model of atherosclerosis. Mol Nutr Food Res 2012;56:1097-1105.
12. Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, Hennig B. Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kB and PPAR signaling. J Am Coll Nutr 2008;27:577-587.
13. Cho YE, Choi JE, Alam MJ, Lee MH, Sohn HY, Beattie JH et al. Zinc deficiency decreased cell viability both in endothelial EA.hy926 cells and mouse aortic culture ex vivo and its implication for anti-atherosclerosis. Nutr Res Pract 2008;2:74-79.
14. Beattie JH, Gordon MJ, Rucklidge GJ, Reid MD, Duncan GJ, Horgan GW et al. Aorta protein networks in marginal and acute zinc deficiency. Proteomics 2008;8:2126-2135.
15. Shah PK. Molecular mechanisms of plaque instability. Curr Opin Lipidol 2007;18:492-499.
16. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006;12:1075-1080.
17. Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, GoddardMet al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2010;106:363-372.
18. Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci 2008; 99:1515-1522.
19. Colvin RA, Holmes WR, Fontaine CP, MaretW. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2010;2:306-317.
20. Tasker PN, Taylor CW, Nixon GF. Expression and distribution of InsP3 receptor subtypes in proliferating vascular smooth muscle cells. Biochem Biophys Res Commun 2000; 273:907-912.
21. Hunter I, Mascall KS, RamosJW, NixonGF.AphospholipaseCg1-activated pathway regulates transcription in human vascular smooth muscle cells. Cardiovasc Res 2011;90: 557-564.
22. Ola MS, NawazM, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem 2011;351:41-58.
23. Scheid MP, Schubert KM, Duronio V. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase. J Biol Chem 1999;274:31108-31113.
24. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999;284:339-343.
25. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91:2703-2711.
26. Harris MH, Thompson CB. The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 2000;7:1182-1191.
27. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 1996; 87:619-628.
28. Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 2011;50:211-221.
29. Su BY, Shontz KM, Flavahan NA, Nowicki PT. The effect of phenotype on mechanical stretch-induced vascular smooth muscle cell apoptosis. J Vasc Res 2006;43:229-237.
30. Oteiza PI, Clegg MS, Zago MP, Keen CL. Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med 2000;28:1091-1099.
31. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smoothmuscle cells. Circulation 1997;96: 3602-3609.
32. Brunt KR, Fenrich KK, Kiani G, Tse MY, Pang SC, Ward CA et al. Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT. Arterioscler Thromb Vasc Biol 2006;26:2027-2034.